Cardiac sodium-glucose co-transporter 1 (SGLT1) contributes to heart failure in a mouse model of diabetic cardiomyopathy

By afschroeder • September 12, 2025

Li Z, Freiberg S, Music ML, Gu L, Nacos S, Phillips JP, Hassan A, Shibbani K, Munir SS, Kumar VK, Halligan L, Michel ME, London BF, Bui N, Cicha M, Buffard V, Abel ED, Ahmad F. Cardiac sodium-glucose co-transporter 1 (SGLT1) contributes to heart failure in a mouse model of diabetic cardiomyopathy. Basic Res Cardiol. 2025 Sep 11. doi: 10.1007/s00395-025-01136-7. Epub ahead of print. PMID: 40932483.

Tags: cardiomyopathy, diabetes, Endocrinology, fibrosis, glucose, Insulin, Oxidative stress, Publications

Colliding crises: The global diabetes pandemic meets climate change-A scoping review

Perez JS, Hudson H, Araneta J, Bedell B, Aikins AD, Dugas LR, Eid M, Eshac Y, Fariduddin M, Fariduddin M, Jong K, Kapwata T, Luke[...]

Glymphatic system impairment in type II diabetes mellitus adults

Roy B, Lubera V, Singh KR, Singh A, Karunamuni DR, Kosoyan DE, Carrier M, Choi SE, Freeby MJ, Kumar R. Glymphatic system impairment in type[...]

Osilodrostat for Cyclic Cushing Disease

Rhyu J, Yu R. Osilodrostat for Cyclic Cushing Disease. AACE Endocrinol Diabetes. 2025 Sep 30;13(1):17-21. doi: 10.1016/j.aed.2025.09.011. PMID: 41641307; PMCID: PMC12866165.